The DC heard how, in December 2022, a labrador called Bella had been stolen from its owner.
That same month, someone who was involved in the theft presented Bella to Dr Kashiv, according to news reports telling him they'd taken the animal because it had been abused.
Dr Kashiv performed surgery to remove her microchip, so she could be re-homed without being traced.
Although there was no suggestion that Dr Khashiv had been involved in the theft, it was alleged that he knew the animal had been stolen.
In January 2024, after pleading guilty, Dr Kashiv was convicted of removing the microchip, contrary to section 5(3) of the Animal Welfare Act 2006, at Stevenage Magistrates’ Court.
He was sentenced to a community order with an unpaid work requirement of 50 hours to be completed within 12 months, and ordered to pay a surcharge to fund victim services of £114 and costs of £85.
Dr Khashiv faced four charges at the RCVS disciplinary hearing, the first being that his conviction rendered him unfit to practise as a veterinary surgeon.
The second charge was that in July 2024, at Stevenage Magistrates’ Court, Dr Kashiv had been made subject to a 5-year Criminal Behaviour Order (CBO) for failing to keep dogs he owned under control and failing to comply with previous orders.
The third charge was that Dr Kashiv’s conduct with regard to the microchip was dishonest, in that he removed it to conceal the labrador’s identity.
The final charge was that Dr Kashiv failed to keep adequate clinical records for the labrador and his conduct was thereby i) misleading and/or ii) dishonest.
From the outset, Dr Kashiv admitted charges one and two and some aspects of charge four.
However, he initially denied that his conduct was at any stage misleading or dishonest and did not accept that his conviction rendered him unfit to practise as a veterinary surgeon or that the admitted charges amount to serious professional misconduct.
In a later submission, Dr Kashiv no longer disputed that his conviction rendered him unfit to practise, or that his behaviour in charges two, three and four amounted to serious professional misconduct.
The Committee considered that in respect of his conviction, Dr Kashiv had breached paragraphs 1.1, 1.3, 6.1, 6.4 and 6.5 of the Code of Professional Conduct for Veterinary Surgeons.
It then took into account mitigating and aggravating factors.
The Committee found no mitigating factors but found the following aggravating factors:
The Committee was satisfied that this conduct fell far below the standard expected of a registered veterinary surgeon and that this rendered him unfit to practise.
In deciding on whether his conduct amounted to serious professional misconduct, the Committee again took into account submissions made both by representatives for the College and for Dr Kashiv, as well as the fact that Dr Kashiv no longer disputed the assertion that his conduct amounted to serious professional misconduct.
The Committee found that Dr Kashiv had breached paragraphs 2.4, 2.5, 6.1, 6.4 and 6.5 of the Code in relation to charges two, three and four.
The Committee again did not find any mitigating factors but found the following aggravating factors:
With regards to charges three and four, Dr Kashiv performed a prohibited procedure on a labrador which was unjustified and resulted in a criminal conviction.
The Committee found that in carrying out the procedure he had acted dishonestly – he had removed the chip in order to conceal the identity of a pet that he knew had been taken from its home.
The dishonesty with regards to not completing any formal clinical records also related directly to his practice as a veterinary surgeon, as part of a cover-up so that nobody would know what had happened to the labrador at the practice.
The Committee was satisfied that Dr Kashiv’s conduct in relation to the labrador amounted to serious professional misconduct.
On deciding on a sanction, the Committee took into account all evidence and documents provided as well as testimonials together with submissions made on behalf of Dr Kashiv and matters of personal mitigation.
In terms of aggravating factors, it found all those already listed in findings for fitness to practise and serious professional misconduct, as well as previous convictions and adverse findings of the College and the fact that Dr Kashiv showed limited insight into his actions.
In terms of mitigating factors, it considered:
Paul Morris, chairing the Committee and speaking on its behalf, said: “The Committee was of the view that the nature and seriousness of Dr Kashiv’s behaviour, which led to the conviction, was fundamentally incompatible with being registered as a veterinary surgeon.”
He added: “In light of these conclusions, the Committee decided that the only appropriate and proportionate sanction in this case was removal from the Register.
"This would not be the case if the Committee were considering the CBO matter alone, when a lesser sanction would have been appropriate.
"However, his actions with regard to the labrador, his limited insight and the fear that he could repeat such behaviour meant that removal was necessary in this case.
“In reaching this decision the Committee recognised the negative impact this would have on Dr Kashiv.
"The Committee had considered with great care all the mitigating factors and the positive statements made about him in the testimonials provided.
"However, the need to protect animal welfare, the reputation of the profession and thus the wider public interest, outweighed Dr Kashiv’s interests and the Committee concluded that removal was the only appropriate and proportionate sanction in this case.”
www.rcvs.org.uk/disciplinary
https://www.dailymail.co.uk/news/article-15069309/Vegan-vet-Animal-Rebellion-activist-steal-pet-dog.html
Designed to help veterinary teams make clearer, more confident clinical decisions, the flowchart provides a step-by-step approach to diagnosing and managing ear disease in dogs and cats.
Renzo Di Florio, Technical Veterinary Adviser at Krka UK, said: “It takes you through each step, from diagnosis to treatment and long-term management, including identifying cases that might benefit from referral.
"It can also help practices to develop an otitis externa management plan protocol that’s useful for the whole team, and that’s practical and easy to integrate into existing workflows.”
One of the main messages in the flowchart is the central role of cytology in otitis management.
Tim said: “Cytology is essential to assess the level of inflammation and detect the presence of bacteria or Malassezia.
"This helps clinicians make informed decisions about whether antibiotics are truly needed.
"In contrast, culture and sensitivity testing can be misleading when used to guide topical therapy.”
https://www.krka.co.uk/veterinary-knowledge-hub
Joint Care contains glucosamine, rosehip, echinacea, and vitamin C, and Supreme Petfoods says it's been developed in response to growing awareness of osteoarthritis (OA) as a significant yet under-diagnosed condition in small mammals.
Supreme points to a retrospective study which identified osteoarthritic lesions in 40% of domestic rabbits, with prevalence strongly correlated with age and body weight.¹
The company says that while definitive prevalence data in guinea pigs is lacking, OA is considered to be common in this species as well.²
Molly Varga, RCVS recognised exotics specialist, said: “Signs of joint pain are often subtle or masked in prey species.
"Proactive use of nutritional supplements like Science Selective Joint Care can help maintain mobility and may delay progression.
"Nutritional support, combined with appropriate husbandry and veterinary care, can make a real difference to long-term quality of life.”
As well as glucosamine, Science Selective Joint Care also contains rosehip, a botanical with claimed anti-inflammatory and chondroprotective properties and echinacea, which has claimed anti-inflammatory, antioxidant and immunomodulatory activity.3,4
Supreme says Vitamin C is an essential nutrient for guinea pigs and beneficial for rabbits, and contributes to normal collagen formation and may help protect joint tissues from oxidative stress.
Claire Hamblion, Marketing Director at Supreme Petfoods, said: “With 45% of pet owners now regularly purchasing supplements for their animals,5 the demand for clinically relevant, species-appropriate products is growing.
"We work closely with veterinary and nutrition experts to ensure our formulations meet emerging needs and Joint Care reflects that commitment.”
Available in 100g packs, Joint Care has a recommended retail price (RRP) of £6.99 and is suitable for rabbits, guinea pigs, and chinchillas.
https://supremepetfoods.com/products/science-selective-care-supplements
References
The BVA is calling on the UK Government to urgently develop a coherent, risk-based national strategy to close the gaps in border biosecurity and protect the UK from devastating diseases like African swine fever and foot-and-mouth disease.
The Environment, Food and Rural Affairs (EFRA) Committee report makes for sobering reading.
It reveals a lack of adequate border control enforcement when it comes to personal imports of meat and other products of animal origin, weak intelligence networks, poor Government interdepartmental working and an absence of a national strategy to manage the significant animal disease and public health risks posed by potentially contaminated products.
The report raises particular concerns about funding cuts for Official Vets at Dover, alongside ministerial comments that appear to dismiss the role of vets in protecting biosecurity.
British Veterinary Association Junior Vice President Rob Williams said: “This report is deeply concerning, exposing serious gaps in border enforcement and warning that large amounts of illegal and potentially contaminated meat continue to enter the UK and make their way on to our plates.
"We cannot know where this meat has come from or if it meets the UK’s high animal welfare and biosecurity standards, and without appropriate checks, we can’t stop illegal meat imports at the border.
"This could have catastrophic and costly impacts on the UK’s food security, public health, and animal health and welfare through the import of exotic animal diseases such as foot-and-mouth disease.
"The findings from this report, coupled with the recent National Audit Office report on animal disease resilience, should act as a wake-up call to Government to urgently deliver a coherent and properly resourced national strategy to tackle illegal meat imports and safeguard the UK’s biosecurity.
“Government vets play a critical role in protecting the nation’s biosecurity but can only do their jobs effectively if they are supported by effective systems.
"Currently, veterinary capacity required to perform checks remains a concern.
"As part of a national action plan, we would like to see better support for vets through a data-driven and risk-based system that is fit for purpose.
"This should also include adequate resources for Official Vets and the agencies tasked with keeping borders secure, which is why we want to see the proposed 70% cuts to Dover Port's budget for spot checks on animal products reversed.”
committees.parliament.uk/writtenevidence/135824/html/
Photo: www.depositphotos.com
The new guidelines have been spearheaded by BEVA Council member Angela Jones (pictured), an equine vet, a mum, and co-founder of Petscribers.
Angela works flexibly and has found this so positively career changing that she wanted to make flexible working opportunities made more readily available to other veterinary professionals.
She said: “Sustainable veterinary care relies on healthier, more balanced teams, and flexibility is key.
"There’s no one-size-fits-all approach.
"Flexible working allows individuals to find balance and prioritise what matters most to them, supporting wellbeing, job satisfaction, and ultimately the quality of care we can provide to our patients and clients.”
“It’s not just beneficial for individuals.
"Practices that embrace flexibility are more likely to attract and retain great people, strengthen their teams, and build sustainable workplaces.”
The Flexible Working Guidelines are designed to give employees the language, tools, and confidence to make a request and help employers deal with requests fairly and see the value of flexibility in improving retention and reducing recruitment costs.
The guidelines include explanations of what flexible working can look like in equine practice, an update on the new Flexible Working Act (April 2024), including the right to request flexibility from day one, and how employers are expected to handle requests, and templates to help both employees and employers start the conversation.
Angela was motivated to produce the flexible working guidelines when she realised her traditional equine role wasn’t giving her the flexibility or professional fulfilment she needed after the birth of her second child.
She said: "I’d often said that on-call was the aspect of the job I found toughest, especially after having children, so I was hesitant about taking on an out-of-hours only role.
“But by turning the problem on its head, decoupling daytime work from on call with Equicall, I truly found balance.
“Flexible working looks different for everyone, and it evolves as life changes.
"What matters is making work, work for you. In equine practice, flexibility isn’t just possible, it’s essential.”
The new Flexible Working Guidelines will be discussed at BEVA Congress during Saturday’s session entitled “Making your veterinary career work” chaired by Mark Tabachnik with Rosie Allister, Carolyne Crowe and Kirstie Pickles on the panel.
http://www.bevacongress.org
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
To refer a case: https://chestergates.org.uk/referral-services.
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
David, Appleton Professor in Equine Surgery, University of Florida (pictured, left), says that despite considerable progress since the 1970's, largely through improved understanding of the diseases involved, diagnostic methods, surgical equipment and materials, and specialised training of surgeons, lingering problems remain and need to be addressed at all levels, not just by surgeons.
He said: “The current high cost of colic surgery can deny many horses a life-saving procedure.
"Pessimism is likely the product of past failures and overemphasis of treatments that are inappropriate or misdirected.
"Delays in referral might seem minor but have devastatingly harmful effects on outcome.
"Owners, primary care veterinarians, and surgeons need to establish an approach to colic based on teamwork, education, and rejection of myths that are widely promulgated.
"I will be looking at the key elements of progress and how they can be applied for future success.”
Professor Scott Weese (pictured right) is Director of the Centre for Public Health and Zoonoses at the University of Guelph.
He will present: "Misconceptions, Myths and Dogmas: moving past old barriers to optimise antimicrobial use in horses", which will challenge the audience to think about what they do with antibiotics and why, with the aim of introducing practical steps to optimise antimicrobial use, leading to improved patient outcomes, easier treatment and minimisation of negative consequences.
Scott said: “We do a lot of things simply because we’ve done them, not because they work or make sense, and we need to look at what we’re doing and the available evidence.
"I will discuss some well-established dogmas that don’t actually make sense, cover some common questions and misconceptions about antibiotic use, and try to help us advance how we use these life-saving drugs that, to some degree, are a non-renewable resource.”
Scott will also be presenting a talk about sampling on the Friday in the antimicrobial stewardship session, with the aim of getting everyone thinking about how we make antibiotic decisions: “There’s a lot of emphasis on submitting cultures, but if we submit bad samples or can’t interpret them, it’s at best a waste of money and at worst can harm patients.”
Book before 6th August to take advantage of early bird prices for BEVA members of £599 for a three-day pass for vets (normal price £699) and £225 for vet nurses (normal price £273) (with concessionary rates available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Early bird rates and practice passes are available until 6 August 2025.
Zenrelia is a new JAK inhibitor which Elanco says provides visible itch relief which lasts 24 hours, from the first dose.1
The company points to a head-to-head study with over 330 dogs across 25 vet clinics, in which Zenrelia was shown to get 45% more itchy dogs back to normal than Apoquel (oclacitinib).1
Elanco says its once-daily dosing may also improve treatment compliance over twice-daily alternatives.
The company also says that Zenrelia has a cost benefit too, presumably meaning it's cheaper than alternatives.
Zenrelia can be given long term with commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.
Elanco UK & Ireland General Manager Matthew Frost said: “With this treatment, we’re looking at happier dogs and their owners, and a more rewarding experience for vets.”
www.zenrelia.co.uk
Reference
For the study, researchers from the RVC, University of Edinburgh and Scotland’s Rural College analysed data from the RVC’s VetCompass Programme on a random sample of 2,440 nail clipping cases taken from over 2 million dogs under UK primary veterinary practice care during 2019, 5.64% of UK dogs (over one in twenty dogs) were found to have had their nails clipped at least once as part of their primary veterinary care each year.
The nail clipping was the primary reason for attending the veterinary visit for more than half (59.40%) of those dogs.
The most cited clinical reasons for nail clipping veterinary visits were overgrown and/or ingrown nails (12.66%) and broken claws or dewclaws (8.84%).
Of the breeds that were most likely to present for nail-clipping, 13.29% of chihuahuas were clipped each year, 12.58% of beagles, 11.98% of greyhounds and 9.36% of pugs.
Dog breeds with a skull shape that deviated from a typical medium-length skull in either direction also had a higher risk of needing nail clipping.
Flat-faced dogs breeds (e.g. pugs, French bulldogs, shih tzus) were 1.67 times more likely to have their nails clipped, while breeds with long faces (e.g. greyhound, whippet) were 1.32 times more likely to have their nails clipped, compared to breeds with a medium length skull (e.g. Labrador retriever, English springer spaniel).
Dog breeds with shortened and often twisted legs (chondrodystrophic breeds) were also 1.44 times more likely to have their nails clipped compared to dog breeds with straight legs.
Age and body weight also affected a dog’s chances of undergoing nail clipping.
Young dogs aged between 1 to 2 years were the most likely to have nail clipping procedures.
Smaller dogs weighing less than 10.00 kg had higher odds of overgrown nails compared to larger dogs weighing 40.00 kg or more.
The researchers say that frequency of nail clipping in primary veterinary care indicates the need for comprehensive teaching of canine nail care in veterinary and veterinary nursing education, as well as proactive veterinary monitoring, nail care protocols and owner education.
Dr Dan O’Neill, Associate Professor of Companion Animal Epidemiology at the RVC and co-author of the paper, said: “This new VetCompass study shows that some dog breeds have more than twice the need to have their nails clipped compared to other breeds.
"This highlights just how distinct humanity has made each dog breed and suggests we are getting close to the time when we should no longer consider all dog breeds as even being the same species.”
Dr Lavin Ahmed, Veterinary Surgeon, President of Protecting Animals in Kurdistan Organization (PAKO) and lead author of the study, said: “When I was first offered nail clipping by RVC VetCompass as my MSc research topic, I honestly underestimated its significance.
"It seemed like just another routine procedure that we all do every day in veterinary practice.
"However, reading the clinical records made it clear that nail care is more than just a trivial grooming procedure but is a genuine welfare issue that deserves much more attention in both veterinary training and owner education.”
The scholarships are designed to support veterinary surgeons who demonstrate exceptional commitment to professional growth and a passion for improving patient outcomes.
Each award covers the tuition fee for the 12-month programmes, including both online learning and practical training sessions.
Applications close for the Small Animal Soft Tissue Scholarship on 15th August 2025, and the Small Animal Medicine Scholarship on the 5th September 2025.
Improve says shortlisted applicants will be assessed based on professional motivation, career aspirations, and commitment to the profession.
https://subscriptions.improveinternational.com/small-animal-medicine-scholarship-2025
https://subscriptions.improveinternational.com/small-animal-soft-tissue-surgery-scholarship-2025
They say that the free system offers an easy way for veterinary practices to improve client service, streamline workflows, and enhance animal welfare.
Boop uses AI and computer vision to auto-populate vaccination details and capture things like microchip numbers, to ensure certificates are positively identifiable and compliant with the RCVS 10 principles of certification and electronic signing guidance.
Pet owners can then store and access digital vaccination certificates on their mobile phone through the Boop app, where they can also look-up chip details, up to 30% of which are not properly registered.
The app also lets owners share vaccination certificates easily with boarding and day care establishments via email or whatsapp.
Charlie said: “Boop brings a vaccination record service fit for 2025, enabling vets to add more value to their vaccination service and owners to care better for their pet.
"By linking to the microchip, vets can be confident that every record belongs to the right pet—making care safer, more accurate, and more convenient.”
Once signed up, practices can start issuing digital vaccination certificates immediately, without changing their existing PMS or workflows.
www.booppet.app/vets
Faecal calprotectin is a calcium-binding protein released into the gut lumen predominantly by neutrophils, and to a lesser extent by monocytes and macrophages, during intestinal inflammation.
Its presence in faeces reflects the degree of neutrophilic infiltration in the gut mucosa, making it a useful biomarker for identifying intestinal inflammation.
Faecal calprotectin lateral flow testing is already used in human health and included in the NICE guidelines for the management of inflammatory bowel disease (IBD)1.
Determining the underlying cause of chronic diarrhoea, vomiting and weight loss in cats and dogs can be complex, often requiring invasive procedures such as endoscopy or biopsy - both of which carry cost, risk, and sometimes practical limitations in general practice.
GIQuest is designed to offer a non-invasive, rapid alternative to support clinical decision-making.
Carus says that whilst not a replacement for histopathology, faecal calprotectin concentrations have been shown to correlate with disease severity in dogs and cats, as measured by tools such as the Canine Chronic Enteropathy Clinical Activity Index (CCECAI).2
New data from the University of Bristol Vet School appears to confirm the test’s ability to differentiate dogs with histologically-confirmed inflammatory enteropathy from healthy controls with high sensitivity (94%) and specificity (96%) using a score threshold of 3mg/kg.2
Carus says the test also performed well in cats, distinguishing those with inflammatory enteropathy from healthy controls with a specificity of 100% and sensitivity of 92%.
In addition, the test detected elevated calprotectin levels consistent with inflammatory gastroenteropathy in 25% of dogs receiving oral NSAIDs, which highlights its potential not only in long-term monitoring but also early in treatment when GI side effects may first emerge.
Jolian Howell of Carus Animal Health said: “Faecal calprotectin testing can provide additional clarity in a range of clinical scenarios.
"It is particularly useful when diagnosing and managing suspected inflammatory enteropathy or food related reactions and for monitoring or screening for GI side effects of oral non-steroidal anti-inflammatories in long term OA therapy regimes.”
The Bristol study also showed that dogs with food-responsive enteropathy had a significant drop in calprotectin concentrations following dietary change, reinforcing the test’s role in tracking treatment response.
Georgie Louca, Veterinary Business Manager for Carus Animal Health, added: ”By providing a measurable, visual indicator of intestinal inflammation, GIQuest also helps support client communication and can improve compliance during treatment or dietary trials.”
GIQuest is designed for use in practice, including during consultations, delivering colour-coded results in 15 minutes.
GIQuest is now available to veterinary practices across the UK and can be ordered through veterinary wholesalers NVS, Covetrus and MWI.
https://carusanimalhealth.com/giquest
The working group, which is led by Gudrun Ravetz, IVC's Group Chief Medical Officer, has been tasked with developing evidence-based, sustainable prescribing practices that protect animal health while safeguarding the planet.
The group comprises experts from within IVC Evidensia’s network who will collaborate with industry and academic partners including Vetoquinol, IDEXX, ESCCAP, and MSD Animal Health to deliver research, education, and practical tools for veterinary teams both inside and outside of IVC Evidensia practices.
Gudrun said: “We’re proud to be investing in this work and setting an example for the profession.
"Responsible parasiticide use is not just a clinical issue, it’s a sustainability imperative.”
Miss Johnson was convicted at North Somerset Magistrates’ Court following a guilty plea of the offence of theft by employee in December 2023, after she stole buprenorphine belonging to Yatton Vets earlier that year.
She was sentenced to a fine of £120, a surcharge of £48, and costs of £85.
There were four further charges against Miss Johnson.
Charge one related to Miss Johnson stealing 5ml of methadone in December 2022 from her employer, Vets4Pets in Bristol, and injecting herself with the methadone.
The police investigated the incident and Miss Johnson accepted a conditional caution for the theft, the condition being she should attend a drug awareness course.
Charge two related to Miss Johnson dishonestly taking a syringe of methadone in August 2023 from her employer, the Langford Small Animal Hospital, and injecting herself with it.
Charge three related to two dates in September 2023 when she dishonestly took methadone, gabapentin and buprenorphine from Yatton Vets, her then employer, injecting herself with the buprenorphine and then working when unfit to do so.
Miss Johnson was later convicted of theft in relation to the buprenorphine (charge five).
Charge four related to an incident in November 2023, when Miss Johnson dishonestly took a syringe of buprenorphine from Bristol PDSA, for the purposes of self-administration, and was dishonest both to other members of staff and in the clinical records about the circumstances of taking the buprenorphine.
Charge five was in relation to Miss Johnson’s criminal conviction.
At the outset of the hearing, Miss Johnson admitted all charges in their entirety.
Having reviewed all the evidence and taken Miss Johnson’s admissions into account, the Committee found each of the charges proved.
After the criminal proceedings had finished and had been reported to the College, Miss Johnson wrote a letter expressing her deepest apologies to both the RCVS and the profession.
Within this she also made it clear that she took full responsibility for her actions.
In a later statement, she added that she had tried to use the experience to learn and improve in every aspect of her career and life and did not want to defend her behaviour.
Within this statement she also retracted a previous request to resign from the register, stating that she would accept any outcome to the investigation.
In deciding whether the proved charges amounted to serious professional misconduct, the Committee took the following aggravating factors into account:
The Committee identified no mitigating factors and concluded that for each of the individual charges Miss Johnson’s conduct fell far short of the conduct expected of a member of the profession and that each of the charges one to four amounted to serious professional misconduct.
In relation to charge five, the criminal conviction, the Committee noted that the nature and the circumstances of the offence involved dishonesty, abuse of her professional position regarding access to controlled drugs, breach of her employer’s trust, and that the misconduct took place notwithstanding an investigation by the police for similar conduct in December 2022.
The Committee therefore concluded that charge five rendered Miss Johnson unfit to practise.
When deciding on a sanction, the Committee took into account mitigating factors, which included:
The Committee found no further aggravating factors at this stage.
Kathryn Peaty, chairing the Committee and speaking on its behalf said: “The Committee considered that the overall misconduct proved so serious and was incompatible with remaining on the register.”
She added: “The Committee accepted that Miss Johnson was currently likely to be drug-free on the basis of her evidence and that of her referee, but it noted that independent testing proving she had been drug free for any period of time was not available to it.
"Furthermore, Miss Johnson had been unable to demonstrate that she had worked without any incident recently as she had accepted she had been dismissed from her recent job.
“Having taken into account all of the aggravating and mitigating factors, and balancing the public interest and the need to uphold and maintain standards within the profession, and having decided that Miss Johnson’s insight was limited, the Committee concluded that the sanction of ‘removal’ was the only proportionate sanction it could impose in this case.
"It also decided that such a sanction maintained public confidence in the veterinary profession, safeguarded animal welfare and protected the public from any future risk of repetition of similar behaviour.
“The Committee therefore directed that the Registrar remove Miss Johnson’s name from the register of veterinary nurses forthwith.”
This annual survey is designed to provide an overview of remuneration levels within the veterinary sector.
It covers everything from basic earnings, bonuses, dividends and overtime, to benefits such as accommodation, car allowances and pensions making it a benchmark for all professionals working in both clinical and non-clinical roles within the veterinary profession.
The main findings of the survey will be published in a report and freely available to all participants who give their email address at the end of the survey.
SPVS members will be able to access the full results with additional commentary and analysis.
https://www.smartsurvey.co.uk/s/FRBTUW/
The centres have cutting-edge facilities, including high-tech audio-visual equipment with ceiling-mounted cameras to relay demonstrations, phantom models for abdominal ultrasound training and advanced simulators for practicing echocardiography.
The courses will be taught mainly by clinicians from across the IVC Evidensia network,
IVC says the centres will deliver 20,000 hours of CPD for its staff this year, and it aims to make its training available to the broader veterinary community towards the end of 2025.
Daniella Dos Santos, Director of Professional Culture at IVC Evidensia, said: “These centres will allow us to provide tailored training, whether you’re just starting your career or you’re looking to develop new skills and techniques.
"The training will help us deliver exceptional care for pets and their owners by ensuring our colleagues and eventually the wider profession continue to grow and develop their expertise.”
PhotonUVC Vet is a non-contact treatment which emits low dose ultraviolet C light at a targeted area.
Photon Therapeutics says the device kills bacteria, viruses, fungi and other infecting organisms while being safe to host tissues.
Other claimed benefits of the device are that it avoids client compliance issues associated with eye-drops, it eliminates the need for antibiotic eye drops, and it is very simple to learn how to use.
The device costs £4,995.
To explain more about The PhotonUVC Vet, Dr. Simon Dean. MBChB, MSc, FRANZCO, FBCLA Chief Scientific Officer at Photon Therapeutics, and Dr. Mark Leddy BVSc, MBA, CEO, will be delivering a CPD presentation at the Exhibitor Showcase Theatre 3: "5 Amazing Seconds – A New Transformative Treatment for Corneal Infections", on Thursday 14th November at 3pm.
There is also a launch event reception at the stand from 16.15 to 18.15 on Thursday 14 November.
https://photon-therapeutics.com/
The new clinic is led by Marie Kubiak, an RCVS Specialist and diplomate in Zoo and Wildlife Medicine and one of only a small number Specialists that are accredited for reptiles, birds, pet mammals, wildlife, zoo species, fish and invertebrates.
The open day offers a chance to see the new clinic, meet the team, find out how it can support your practice and discuss any challenging cases you have.
Light snacks and drinks will be provided.
RSVP: evolutionexoticsreferrals@gmail.com
https://evolutionexoticsreferrals.co.uk
Evolution Exotics Referrals, Tenbury Road, Cleobury Mortimer, South Shropshire, DY14 0AD
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
Krka says Arocenia provides fast, broad-spectrum anti-emetic efficacy with a 24-hour duration of action following a single daily dose.
It can be administered intravenously or subcutaneously and is supplied in 20 ml multi-dose vials, allowing up to 40 punctures per vial and a 60-day open vial shelf life.
Renzo Di Florio, Krka’s Technical Veterinary Adviser, commented “Vomiting is one of the most common presenting signs in small animal practice, and maropitant is a medication you’ll find on just about every vet’s dispensary shelf. With Arocenia, we’re adding a cost-effective formulation to the available options.”
https://www.krka.co.uk//products/our-products/animal-health/arocenia-10mgml-solution-for-injection
The BSAVA says there unique opportunities and risks to the use of antibiotics in rabbits.
For example, antibiotic combination therapy, which is discouraged in dogs and cats, can be safe and effective in this species.
Also, careful selection of appropriate antibiotics, in terms of active substance, dose and route of administration, is crucial when treating rabbits due to the risk of enterotoxaemia. The new guide gives advice on diagnosing bacterial infections, likely causal organisms and appropriate antibiotic and non-antibiotic management.
The guide covers dacryocystitis, ear disease, facial abscesses, enteritis, urinary tract disease, and upper and lower respiratory tract disease. John Chitty, one of the authors, said: “Choosing an antibiotic for rabbits is not simple.
"Their diseases do not necessarily mirror those of dogs and cats, and they do have gut sensitivities to certain antimicrobials.
"However, like dogs and cats, there are situations where antibiotics are not needed where we once thought they were.
"This is especially important in reducing antibiotic usage in rabbits and, of course, in reducing use of critically important antibiotics in them as well.
"We hope this guide will help practitioners to see when antibiosis is needed, what choices are available and how to sample and select the most appropriate drug if needed.” The new guide is free to all and can be accessed at bsavalibrary.com/protectme.
UK Pet Food says that with pet owners increasingly turning to their vets for nutrition guidance, this course is designed to equip veterinary teams with the knowledge and confidence to offer clear, evidence-based advice.
The course offers 20 hours of CPD comprised of on-demand modules and live Q&A sessions covering pet food formats, clinical nutrition, pet obesity, regulatory frameworks, sustainability, and client communication.
There'll be contributions from independent speakers and chairs from leading academics, veterinary nutritionists, and industry experts
Sarah Hormozi, Head of Science & Education at UK Pet Food, said: “This course is about helping veterinary professionals critically evaluate the science behind pet nutrition.
“We’ve worked with board-certified veterinary nutritionists, academics, industry experts, and veterinary associations to develop a resource that supports everyday clinical conversation - giving the veterinary community practical tools and confidence to talk about pet food and nutrition with clarity and credibility.”
There are early bird tickets for £90 if you book by 15th August 2025.
https://thewebinarvet.com/events/uk-pet-food-2025
https://www.ukpetfood.org
The merger brings together Improve International’s global reach and postgraduate qualification programmes with Central CPD’s practitioner-led Continuing Professional Development training and digital learning infrastructure.
Improve says the merger will better position the two companies to meet the growing and evolving needs of the profession.
However, the veterinary training marketplace has been hit recently by news that IVC Evidensia has opened two in-house training centres, one in Scotland and one in the Midlands, perhaps precipitating some consolidation, especially since IVC has announced plans to offer CPD to the wider profession later this year.
Jonathan Hill, UK country manager at Dômes Pharma said: "Dômes Pharma is really excited to be extending our pet anxiety range to help vets manage cases in this complex area.
https://domespharma.co.uk/products/fluoxevet/